114 related articles for article (PubMed ID: 27384850)
1. [Significance of TET2 mutations in myeloid and lymphoid neoplasms].
Chiba S
Rinsho Ketsueki; 2016 Jun; 57(6):715-22. PubMed ID: 27384850
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of TET2 in hematologic malignancies.
Chiba S
Int J Hematol; 2017 Jan; 105(1):17-22. PubMed ID: 27848178
[TBL] [Abstract][Full Text] [Related]
3. [TET2 as a gatekeeper for hematologic malignancies].
Muto H; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875
[TBL] [Abstract][Full Text] [Related]
4. Mutation in TET2 in myeloid cancers.
Delhommeau F; Dupont S; Della Valle V; James C; Trannoy S; Massé A; Kosmider O; Le Couedic JP; Robert F; Alberdi A; Lécluse Y; Plo I; Dreyfus FJ; Marzac C; Casadevall N; Lacombe C; Romana SP; Dessen P; Soulier J; Viguié F; Fontenay M; Vainchenker W; Bernard OA
N Engl J Med; 2009 May; 360(22):2289-301. PubMed ID: 19474426
[TBL] [Abstract][Full Text] [Related]
5. Age-Associated
Ferrone CK; Blydt-Hansen M; Rauh MJ
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963585
[TBL] [Abstract][Full Text] [Related]
6. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
Quivoron C; Couronné L; Della Valle V; Lopez CK; Plo I; Wagner-Ballon O; Do Cruzeiro M; Delhommeau F; Arnulf B; Stern MH; Godley L; Opolon P; Tilly H; Solary E; Duffourd Y; Dessen P; Merle-Beral H; Nguyen-Khac F; Fontenay M; Vainchenker W; Bastard C; Mercher T; Bernard OA
Cancer Cell; 2011 Jul; 20(1):25-38. PubMed ID: 21723201
[TBL] [Abstract][Full Text] [Related]
7. TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.
Shimoda K; Shide K; Kameda T; Hidaka T; Kubuki Y; Kamiunten A; Sekine M; Akizuki K; Shimoda H; Yamaji T; Nakamura K; Abe H; Miike T; Iwakiri H; Tahara Y; Sueta M; Yamamoto S; Hasuike S; Nagata K; Kitanaka A
J Clin Exp Hematop; 2015; 55(3):145-9. PubMed ID: 26763362
[TBL] [Abstract][Full Text] [Related]
8. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
9. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
[TBL] [Abstract][Full Text] [Related]
10. Novel Mutations and Decreased Expression of the Epigenetic Regulator
Potus F; Pauciulo MW; Cook EK; Zhu N; Hsieh A; Welch CL; Shen Y; Tian L; Lima P; Mewburn J; D'Arsigny CL; Lutz KA; Coleman AW; Damico R; Snetsinger B; Martin AY; Hassoun PM; Nichols WC; Chung WK; Rauh MJ; Archer SL
Circulation; 2020 Jun; 141(24):1986-2000. PubMed ID: 32192357
[TBL] [Abstract][Full Text] [Related]
11. Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.
Yeh CH; Bai XT; Moles R; Ratner L; Waldmann TA; Watanabe T; Nicot C
Mol Cancer; 2016 Feb; 15():15. PubMed ID: 26880370
[TBL] [Abstract][Full Text] [Related]
12. TET2 mutation in diffuse large B-cell lymphoma.
Kubuki Y; Yamaji T; Hidaka T; Kameda T; Shide K; Sekine M; Kamiunten A; Akizuki K; Shimoda H; Tahira Y; Nakamura K; Abe H; Miike T; Iwakiri H; Tahara Y; Sueta M; Yamamoto S; Hasuike S; Nagata K; Kitanaka A; Shimoda K
J Clin Exp Hematop; 2017; 56(3):145-149. PubMed ID: 28331128
[TBL] [Abstract][Full Text] [Related]
13. TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.
Kosmider O; Gelsi-Boyer V; Ciudad M; Racoeur C; Jooste V; Vey N; Quesnel B; Fenaux P; Bastie JN; Beyne-Rauzy O; Stamatoulas A; Dreyfus F; Ifrah N; de Botton S; Vainchenker W; Bernard OA; Birnbaum D; Fontenay M; Solary E;
Haematologica; 2009 Dec; 94(12):1676-81. PubMed ID: 19797729
[TBL] [Abstract][Full Text] [Related]
14. TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns.
Damm F; Markus B; Thol F; Morgan M; Göhring G; Schlegelberger B; Krauter J; Heuser M; Bernard OA; Ganser A
Genes Chromosomes Cancer; 2014 Oct; 53(10):824-32. PubMed ID: 24898826
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis.
Cai Z; Kotzin JJ; Ramdas B; Chen S; Nelanuthala S; Palam LR; Pandey R; Mali RS; Liu Y; Kelley MR; Sandusky G; Mohseni M; Williams A; Henao-Mejia J; Kapur R
Cell Stem Cell; 2018 Dec; 23(6):833-849.e5. PubMed ID: 30526882
[TBL] [Abstract][Full Text] [Related]
16. [TET2 gene in hematological diseases].
Li S; Wang XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):836-41. PubMed ID: 24989305
[TBL] [Abstract][Full Text] [Related]
17. Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway.
Palam LR; Mali RS; Ramdas B; Srivatsan SN; Visconte V; Tiu RV; Vanhaesebroeck B; Roers A; Gerbaulet A; Xu M; Janga SC; Takemoto CM; Paczesny S; Kapur R
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467326
[TBL] [Abstract][Full Text] [Related]
18. Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia.
Shih AH; Jiang Y; Meydan C; Shank K; Pandey S; Barreyro L; Antony-Debre I; Viale A; Socci N; Sun Y; Robertson A; Cavatore M; de Stanchina E; Hricik T; Rapaport F; Woods B; Wei C; Hatlen M; Baljevic M; Nimer SD; Tallman M; Paietta E; Cimmino L; Aifantis I; Steidl U; Mason C; Melnick A; Levine RL
Cancer Cell; 2015 Apr; 27(4):502-15. PubMed ID: 25873173
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.
Asmar F; Punj V; Christensen J; Pedersen MT; Pedersen A; Nielsen AB; Hother C; Ralfkiaer U; Brown P; Ralfkiaer E; Helin K; Grønbæk K
Haematologica; 2013 Dec; 98(12):1912-20. PubMed ID: 23831920
[TBL] [Abstract][Full Text] [Related]
20. TET2 missense variants in human neoplasia. A proposal of structural and functional classification.
Bussaglia E; Antón R; Nomdedéu JF; Fuentes-Prior P
Mol Genet Genomic Med; 2019 Jul; 7(7):e00772. PubMed ID: 31187595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
